Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes
Cannara Biotech (OTCQB: LOVFF) has secured preliminary acceptance from SQDC for 5 vape cartridge products to be distributed across all Québec retail stores starting November 2025. The company's products will represent 20% of the 25 vape cartridge SKUs planned for in-store distribution by year-end.
The company, which operates two mega facilities in Québec totaling over 1,650,000 sq. ft., will introduce both live resin and live rosin vape cartridges. This launch marks Québec's entry into the vape cartridge market, with significant potential given that the SQDC reported $741.5 million in revenue for 2024. Market research indicates 25% of Québec consumers used vapes in the past year, with vape segments representing approximately 15% of total sales in other major Canadian provinces.
Cannara Biotech (OTCQB: LOVFF) ha ottenuto l'accettazione preliminare da parte di SQDC per 5 prodotti di cartucce vape che saranno distribuiti in tutti i negozi al dettaglio del Québec a partire da novembre 2025. I prodotti dell'azienda rappresenteranno il 20% dei 25 SKU di cartucce vape pianificati per la distribuzione in negozio entro la fine dell'anno.
L'azienda, che gestisce due mega strutture in Québec per un totale di oltre 1.650.000 piedi quadrati, introdurrà cartucce vape sia di resina viva che di rosin vivo. Questo lancio segna l'ingresso del Québec nel mercato delle cartucce vape, con un potenziale significativo dato che la SQDC ha riportato un fatturato di 741,5 milioni di dollari per il 2024. Le ricerche di mercato indicano che il 25% dei consumatori del Québec ha utilizzato vape nell'ultimo anno, con i segmenti vape che rappresentano circa il 15% delle vendite totali in altre importanti province canadesi.
Cannara Biotech (OTCQB: LOVFF) ha asegurado la aceptación preliminar de SQDC para 5 productos de cartuchos vape que serán distribuidos en todas las tiendas minoristas de Quebec a partir de noviembre de 2025. Los productos de la compañía representarán el 20% de los 25 SKU de cartuchos vape planeados para la distribución en tienda antes de fin de año.
La empresa, que opera dos mega instalaciones en Quebec con un total de más de 1,650,000 pies cuadrados, introducirá cartuchos vape tanto de resina viva como de rosin vivo. Este lanzamiento marca la entrada de Quebec en el mercado de cartuchos vape, con un potencial significativo dado que SQDC reportó $741.5 millones en ingresos para 2024. La investigación de mercado indica que el 25% de los consumidores de Quebec usaron vapeadores en el último año, con segmentos de vape que representan aproximadamente el 15% de las ventas totales en otras provincias importantes de Canadá.
Cannara Biotech (OTCQB: LOVFF)는 2025년 11월부터 퀘벡 전역 소매점에서 유통될 5종의 베이프 카트리지 제품에 대해 SQDC로부터 예비 승인을 받았습니다. 회사의 제품은 연말까지 매장 유통 예정인 25종의 베이프 카트리지 SKU 중 20%를 차지할 예정입니다.
퀘벡에 총 1,650,000 평방피트 규모의 두 개 대형 시설을 운영하는 이 회사는 라이브 레진과 라이브 로신 베이프 카트리지를 모두 선보일 예정입니다. 이번 출시는 퀘벡이 베이프 카트리지 시장에 진입하는 신호탄으로, SQDC가 2024년에 7억 4,150만 달러의 매출을 보고한 점에서 큰 잠재력을 가지고 있습니다. 시장 조사에 따르면 퀘벡 소비자의 25%가 지난 1년간 베이프를 사용했으며, 베이프 부문은 다른 주요 캐나다 주에서 전체 매출의 약 15%를 차지하고 있습니다.
Cannara Biotech (OTCQB : LOVFF) a obtenu une acceptation préliminaire de la part de la SQDC pour 5 produits de cartouches vape qui seront distribués dans tous les magasins de détail du Québec à partir de novembre 2025. Les produits de l'entreprise représenteront 20 % des 25 références de cartouches vape prévues pour une distribution en magasin d'ici la fin de l'année.
L'entreprise, qui exploite deux méga installations au Québec totalisant plus de 1 650 000 pieds carrés, introduira des cartouches vape à base de résine vivante et de rosin vivant. Ce lancement marque l'entrée du Québec sur le marché des cartouches vape, avec un potentiel important étant donné que la SQDC a rapporté un chiffre d'affaires de 741,5 millions de dollars pour 2024. Les études de marché indiquent que 25 % des consommateurs du Québec ont utilisé des vapes au cours de l'année écoulée, les segments vape représentant environ 15 % des ventes totales dans d'autres grandes provinces canadiennes.
Cannara Biotech (OTCQB: LOVFF) hat eine vorläufige Zulassung von der SQDC für 5 Vape-Kartuschenprodukte erhalten, die ab November 2025 in allen Einzelhandelsgeschäften in Québec vertrieben werden sollen. Die Produkte des Unternehmens werden 20 % der 25 Vape-Kartuschen-SKUs ausmachen, die bis zum Jahresende im Laden vertrieben werden sollen.
Das Unternehmen, das zwei Mega-Anlagen in Québec mit insgesamt über 1.650.000 Quadratfuß betreibt, wird sowohl Live Resin als auch Live Rosin Vape-Kartuschen einführen. Dieser Start markiert den Eintritt Québecs in den Vape-Kartuschen-Markt, mit erheblichem Potenzial, da die SQDC für 2024 einen Umsatz von 741,5 Millionen US-Dollar meldete. Marktforschungen zeigen, dass 25 % der Verbraucher in Québec im vergangenen Jahr Vape-Produkte genutzt haben, wobei Vape-Segmente in anderen großen kanadischen Provinzen etwa 15 % des Gesamtumsatzes ausmachen.
- Secured 20% share (5 SKUs) of Quebec's new vape cartridge category
- Currently Canada's #1 premium live resin vape cartridge provider
- Entering Quebec's untapped vape market worth $741.5M in total cannabis sales
- Vertical integration enables production of additive-free vape formulations
- Strong market potential with 25% of Quebec consumers already using vapes
- Product launch delayed until November 2025 (Q1 FY2026)
- Entering as last major province to allow vape cartridges
- Subject to Quebec's specific category regulations
MONTREAL, July 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., is proud to announce the preliminary acceptance by the Société Québécoise du Cannabis (“SQDC”) of five vape cartridge products to be distributed across all Québec retail stores in November 2025 (Q1 FY2026), in addition to being sold online via SQDC’s e-commerce website, SQDC.ca.
“We are incredibly proud to announce our preliminary approval of 5 live resin and live rosin vape cartridges to be distributed across Québec’s 107 retail stores. These 5 SKUs represent
“We are excited to enter Québec’s vape cartridge category launch with our most popular strains in live resin format. Our vertical processes and strong R&D have enabled the creation of vape formulations with no additives, an expertise we developed in becoming Canada’s #1 premium live resin vape cartridge provider over the last 12 months1,” said Nicholas Sosiak, CFO of Cannara Biotech. “We are eager to continue our success as Canada’s leading premium live resin vape brand and look forward to offering the same premium-quality vape cartridge experience to customers in our home province of Québec, the last major province to allow vape cartridges.”
Québec Vape Market Opportunity
The SQDC reported
Live Rosin Vape Cartridge Launch
Cannara is also proud to announce its first entry into the live rosin vape cartridge category. These live rosin vapes represent the highest-quality flower input — grown, flash-frozen, and extracted entirely in-house at our Valleyfield and Farnham facilities in Québec.
“This launch of live rosin vapes represents the culmination of months of research and development around genetic selection, process refinement, and hardware,” said Nicholas Sosiak, CFO of Cannara Biotech. “We are excited to bring solventless vapes to our home market of Québec for the province’s vape cartridge category launch and see opportunity for further provincial rollouts in the future.”
CONTACT
| Nicholas Sosiak, CPA, CA Chief Financial Officer nick@cannara.ca | Zohar Krivorot President & Chief Executive Officer zohar@cannara.ca |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
ABOUT CANNARA
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
CAUTIONARY STATEMENT REGARDING “FORWARD-LOOKING” INFORMATION
This news release may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required under applicable securities legislation. All statements other than statements of historical facts included in this document constitute forward-looking information.
Forward-looking statements relate to future events or future performance and reflect Company management’s expectations or beliefs regarding future events and include, but are not limited to, the Company and its operations, its projections or estimates about its future business operations, its planned expansion activities, anticipated product offerings, the adequacy of its financial resources, the ability to adhere to financial and other covenants under lending agreements, future economic performance, and the Company’s ability to become a leader in the field of cannabis cultivation, production, and sales.
In certain cases, forward-looking statements can be identified by the use of words such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “occur” or “be achieved” or the negative of these terms or comparable terminology. In this document, certain forward-looking statements are identified by words including “may,” “future,” “expected,” “intends” and “estimates.” By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
Forward-looking information is based upon a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those that are disclosed in, or implied by, such forward-looking information. These risks and uncertainties include, but are not limited to, the risk factors which are discussed in greater detail under “Risk Factors” in the Company’s AIF available on SEDAR+ at www.sedarplus.ca and under the “Investor Area” section of our website at https://www.cannara.ca/en/investor-area.
Other risks not presently known to the Company or that the Company believes are not significant could also cause actual results to differ materially from those expressed in its forward-looking statements. Although the forward-looking information contained herein is based upon what we believe are reasonable assumptions, readers are cautioned against placing undue reliance on this information since actual results may vary from the forward-looking information. Certain assumptions were made in preparing the forward-looking information concerning the availability of capital resources, business performance, market conditions, as well as customer demand. Consequently, all of the forward-looking information contained herein is qualified by the foregoing cautionary statements, and there can be no guarantee that the results or developments that we anticipate will be realized or, even if substantially realized, that they will have the expected consequences or effects on our business, financial condition or results of operation. Unless otherwise noted or the context otherwise indicates, the forward-looking information contained herein is provided as of the date hereof, and we do not undertake to update or amend such forward-looking information whether as a result of new information, future events or otherwise, except as may be required by applicable law.
1 Turff Analytics
2 Rapport Annuel 2025; SQDC
3 Les habitudes de consommation de cannabis au Québec en 2024; Institut de la statistique du Québec.
FAQ
When will Cannara Biotech (LOVFF) launch its vape products in Quebec?
How many vape cartridge SKUs will Cannara have in Quebec's SQDC stores?
What is the market potential for vape products in Quebec?
What types of vape products will Cannara offer in Quebec?
Where will Cannara's vape products be available in Quebec?
